Other

Zofran (Ondansetron)

* For illustration purpose only

Zofran (Ondansetron)

Short description

Learn more

Zofran (Ondansetron) 8mg 30 pills 30 pills

158,200.09 ₩

Zofran (Ondansetron) 8mg 60 pills 60 pills

206,628.68 ₩

Zofran (Ondansetron) 8mg 90 pills 90 pills

253,442.99 ₩

Zofran (Ondansetron) 8mg 120 pills 120 pills

301,871.59 ₩

Zofran (Ondansetron) 8mg 180 pills 180 pills

397,114.50 ₩

Zofran (Ondansetron) 8mg 240 pills 240 pills

603,743.18 ₩

Zofran (Ondansetron) 8mg 270 pills 270 pills

650,557.49 ₩

Zofran (Ondansetron) 8mg 360 pills 360 pills

794,229.00 ₩

Zofran (Ondansetron) 4mg 30 pills 30 pills

142,057.22 ₩

Zofran (Ondansetron) 4mg 60 pills 60 pills

172,728.66 ₩

Zofran (Ondansetron) 4mg 90 pills 90 pills

205,014.40 ₩

Zofran (Ondansetron) 4mg 120 pills 120 pills

235,685.84 ₩

Zofran (Ondansetron) 4mg 180 pills 180 pills

298,643.02 ₩

Zofran (Ondansetron) 4mg 240 pills 240 pills

471,371.68 ₩

Zofran (Ondansetron) 4mg 270 pills 270 pills

502,043.13 ₩

Zofran (Ondansetron) 4mg 360 pills 360 pills

595,671.75 ₩

158200.09

In Stock

added to cart

Shipping

avrg. 5-9 days

Guaranteed delivery time 16 days

Guaranteed delivery time 16 days

Dosages mentioned (EU), are shipped inside Europe and guarantee faster time in delivery.
Payment
Upgrade and save. Add worth of items to cart and get free shipping

Shipping free of charge.

322857.32 ₩

Other

Zofran (Ondansetron)

Commercial Name: Zofran

Active Ingredient: Ondansetron

Production form: pills

Utilization: Used for preventing nausea and vomiting associated with cancer chemotherapy or surgery

Available Dosage: 8mg

Common use

Zofran is a prescription medicine that has been licensed to prevent nausea and vomiting due to several causes

Doses and directions

The dose of Zofran depends on the type of chemotherapy -high risk for nausea and vomiting or medium risk.

High-risk chemotherapy: The dose of Zofran for high-risk chemotherapy is Zofran 24 mg (taken as three 8 mg tablets) 30 minutes before chemotherapy.

Medium-risk chemotherapy: The dose of Zofran for medium-risk chemotherapy is Zofran 8 mg twice daily. The first dose should be taken 30 minutes before chemotherapy, and the second dose should be taken eight hours after the first dose. After that, Zofran should be taken twice a day (about every 12 hours) until one to two days after chemotherapy.

Precations

You should talk with your healthcare provider prior to taking Zofran if you have:

Liver problems, including cirrhosis,an arrhythmia (an irregular heart rhythm), especially long QT syndrome, phenylketonuria, any allergies, including allergies to foods, dyes, or preservatives.

Also, let your healthcare provider know if you:are pregnant or thinking of becoming pregnant, breastfeeding, have severe or constant nausea or vomiting that is not helped by Zofran. Also talk with your healthcare provider if you are vomiting blood, Have severe vomiting and diarrhoea. This combination of problems can lead to dehydration and electrolyte imbalances.

Side effects

If you develop any sexual side effects while taking Zofran, be sure to talk with your healthcare provider

Drug interactions

The following sections explain in detail the potentially negative interactions that can occur when Zofran is combined with any of the drugs listed above.

Apomorphine, Carbamazepine, Phenytoin, Rifampicin, drugs Containing Tramadol.

Missed dose

If you miss a dose of Zofran and are taking it regularly, you should take it as soon as you can remember it. If you miss for long time and it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at a time to compensate fro the missed dose.

Storage

Zofran should be stored at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store it away from heat, moisture, and direct light, in a tight, light-resistant container. Do not store in the bathroom. Keep Zofran out of the reach of children.

Add Review

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, to

First Name

Last Name

Age

Title

Review

Effectiveness
Ease of use/handling
Price-performance ratio